ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,413.74
-0.37%
Dow Jones
38,375.47
-0.70%
US Dollar vs MXN
18.57762
0.84%
Brent Oil
82.615
0.78%
Bitcoin
66,916.27
0.24%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Australia
  5. ASX
  6. Donaco International Ltd (DNA)

  7. Donaco International Ltd (DNA) Noticias

DNA

Donaco (DNA)

Donaco International Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:ASX:DNA
FechaHoraFuenteTítuloSímboloCompañía
10/11/201517:52The Motley FoolPacker backs Crown Resorts Ltd with $200 million betASX:DNADonaco International Ltd
27/03/200910:13Dow Jones NewsUPDATE: FDA 'Unclear' If Avastin Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
27/03/200909:35Dow Jones NewsFDA 'Unclear' If Genentech Drug Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
26/03/200904:23Dow Jones NewsUPDATE: Roche Effectively Seals $46.8 Billion Genentech TakeoverNYSE:DNAGenentech Inc.
26/03/200902:05Dow Jones NewsRoche Completes Genentech Takeover, Holds 93.2%NYSE:DNAGenentech Inc.
26/03/200901:37Dow Jones NewsRoche Completes Tender Offer For Genentech, Holds 93.2%NYSE:DNAGenentech Inc.
25/03/200907:44Dow Jones News2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay PlanNYSE:DNAGenentech Inc.
25/03/200905:43Dow Jones NewsUPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGMNYSE:DNAGenentech Inc.
24/03/200913:08Dow Jones NewsRoche Says RiskMetrics Backs Genentech Takeover At $95/ShareNYSE:DNAGenentech Inc.
19/03/200912:09Dow Jones NewsEU Panel Backs Novartis' Glivec In Kit-positive GISTNYSE:DNAGenentech Inc.
18/03/200908:55Dow Jones NewsRoche Shares Down On Actemra; Herceptin Success Of Little HelpNYSE:DNAGenentech Inc.
18/03/200902:16Dow Jones NewsRoche's Herceptin Extends Life In Aggressive Stomach CancerNYSE:DNAGenentech Inc.
18/03/200901:33Dow Jones NewsRoche: Herceptin Prolongs Life In Stomach CancerNYSE:DNAGenentech Inc.
17/03/200923:32Dow Jones NewsUPDATE: Chugai,Roche Face Arthritis Drug Side Effect SetbackNYSE:DNAGenentech Inc.
17/03/200920:05Dow Jones NewsChugai:Undeniable Actemra Side Effects Tied To Patient DeathsNYSE:DNAGenentech Inc.
17/03/200917:54Dow Jones NewsBiotechnology Group Praises Biologic Drugs BillNYSE:DNAGenentech Inc.
17/03/200915:29Dow Jones News5th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
17/03/200914:25Dow Jones News4th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
17/03/200912:53Dow Jones News3rd UPDATE: Pfizer Launches $13.5 Billion Bond Offer; Pricing TuesdayNYSE:DNAGenentech Inc.
17/03/200912:01Dow Jones News2ndUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
17/03/200911:13Dow Jones NewsUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
16/03/200915:57Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
16/03/200913:49Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
16/03/200901:37Dow Jones NewsRoche Acquires Innovatis AG For EUR15 MillionNYSE:DNAGenentech Inc.
13/03/200907:45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNYSE:DNAGenentech Inc.
12/03/200914:15Dow Jones NewsUS Antitrust Review May Not Pose Threat To Drug Co MergersNYSE:DNAGenentech Inc.
12/03/200909:06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionNYSE:DNAGenentech Inc.
12/03/200906:10Dow Jones News4th UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
12/03/200903:32Dow Jones News3rd UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
12/03/200902:49Dow Jones NewsRoche Chairman: Friendly Deal With Genentech Cuts Out UncertaintyNYSE:DNAGenentech Inc.
 Showing the most relevant articles for your search:ASX:DNA

Su Consulta Reciente

NYSE
MCD
McDonalds
AMEX
XLE
Energy Select Sector SPDR
NYSE
VZ
Verizon Communications
FX
EURMXN
Euro vs MXN
COIN
BTCUSD
Bitcoin
CCOM
US500
US 500
NYSE
DIS
Walt Disney
CCOM
SILVER
SILVER
USOTC
RHHBY
Roche (QX)
NASDAQ
TSLA
Tesla
NYSE
NKE
Nike
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
KO
Coca Cola
FX
USDMXN
US Dollar vs MXN
COIN
SOLUSD
Solana
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados